Penpulimab (AK105)

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

Note: Penpulimab is approved in China, but does not appear to have a brand name at this time.

Mechanism of action

PD-1 inhibitor

Diseases for which it is used

History of changes in NMPA indication

Also known as

  • Code name: AK105